Aurobindo Pharma Receives USFDA Approval for Dextromethorphan Polistirex Extended-Release Oral Suspension
Aurobindo Pharma has received final approval from the USFDA to market Dextromethorphan Polistirex Extended-Release Oral Suspension (30 mg/5…